A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer (Q33409364)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer |
scientific article |
Statements
1 reference
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer (English)
1 reference
Henry Pitot
1 reference
Charles Erlichman
1 reference
Joel Picus
1 reference
Winston Tan
1 reference
Ulka Vaishampayan
1 reference
Roberto Pili
1 reference
Rui Qin
1 reference
P J Flynn
1 reference
Michael Millward
1 reference
Wing Ming Ho
1 reference
Kiersten M Miles
1 reference
26 July 2013
1 reference
1 reference
11
1 reference
477-483
1 reference
Identifiers
1 reference
1 reference
1 reference